Wednesday, October 14, 2026

Search
HomeHealth NewsMore research links GLP-1 drugs to potentially blinding eye diseases
Health News

More research links GLP-1 drugs to potentially blinding eye diseases

0
5
- Advertisement -

New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images
  • The most commonly used types of GLP-1 receptor agonists are semaglutide and tirzepatide, which are used to treat type 2 diabetes and aid weight loss.
  • Past studies have linked GLP-1 medications to a risk of potentially blinding eye diseases.
  • A new study reports that older adults with diabetes taking any type of GLP-1 medication…

Click here to view the original article.

- Advertisment -
Previous article
Designing for urgency, collaboration, and clarity
Next article
Quick-Thinking Zoo Elephant Rescued a Drowning Gazelle with its Trunk

RELATED ARTICLES

- Advertisement -

Recently Viewed

Load more

FEATURED

POPULAR POSTS

POPULAR CATEGORY

The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

FOLLOW US

© 2024 Australian Online News | Privacy Policy